Pictet Asset Management (UK)’s ChemoCentryx, Inc. CCXI Stock Holding History

Pictet Asset Management (UK)’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,222,487	Closed	-$62.6M	–	1871
2021 Q1	$62.6M	Sell	1,222,487 -19,546	-2%	-$1.18M	0.08%	285
2020 Q4	$76.9M	Sell	1,242,033 -56,044	-4%	-$3.21M	0.1%	243
2020 Q3	$71.1M	Buy	1,298,077 +97,462	+8%	+$5.25M	0.11%	215
2020 Q2	$69.1M	Buy	1,200,615 +442,527	+58%	+$24.1M	0.12%	212
2020 Q1	$30.5M	Buy	+758,088	New	+$32.2M	0.07%	291

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pictet Asset Management (UK)'s CCXI Position: Q2 2021 in Review

Pictet Asset Management (UK) sold out of ChemoCentryx, Inc. (CCXI) in Q2 2021, closing a stake of 1,222,487 shares — an estimated $62.6M sold.

Pictet Asset Management (UK) first reported a position in CCXI in Q1 2020 and held it in 5 quarters. The position peaked at $76.9M in Q4 2020. 146 funds tracked by Wall St. Rank hold CCXI as of Q2 2021.

Pictet Asset Management (UK) reported no remaining ChemoCentryx, Inc. position as of Q2 2021 after selling out during the quarter.
Pictet Asset Management (UK) sold 1,222,487 ChemoCentryx, Inc. shares in Q2 2021, an estimated $62.6M.
Pictet Asset Management (UK) first reported a position in ChemoCentryx, Inc. in Q1 2020 and held it in 5 quarters.
Pictet Asset Management (UK)'s ChemoCentryx, Inc. position peaked at $76.9M in Q4 2020.
146 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.